STUDYING INTERNATIONAL COMPETITIVENESS IN PHARMACEUTICAL SECTOR IN SELECTED DEVELOPED COUNTRIES

Seyede Zeinab Mousavi; Saeed Rasekhi; Mina Golestani; Ali Imani

doi:10.22159/ajpcr.2018.v11i3.21554

Authors

Seyede Zeinab Mousavi Department of Economics, Faculty of Economics and Administrative Sciences, University of Mazandaran, Babolsar, Iran.
Saeed Rasekhi Department of Economics, Faculty of Economics and Administrative Sciences, University of Mazandaran, Babolsar, Iran.
Mina Golestani Department of Road Traffic Injuries Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Ali Imani Department of Health Economics, Health Services Management Research Center, Faculty of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i3.21554

Keywords:

Competitiveness, Revealed comparative advantage, Intra-industry trade, Pharmaceutical industry, Selected countries

Abstract

Â Objectives: Competitiveness is the ability of countries in increasing market share, profits, value added, and staying at the scene of fair and international competition for a long period of time. This is realized through market authority and establishing activities based on comparative and competitive advantages. On the other hand, the research-based pharmaceutical industry makes a major contribution to the prosperity of the world economy. It is a robust sector that has been one of the pillars of industrialized economies and is increasingly recognized as an important sector in the developing world as well. Furthermore, global sales of pharmaceutical products represent the international spread of medical technology that comes as the result of highly intensive R and D efforts in the exporting countries (International Federation of Pharmaceutical Manufacturers and Associations, 2012). The present study aimed to analyze and investigate the international competitiveness of pharmaceutical sector in selected developed countries using traditional and new indices of competitiveness.

Methods: In this study, revealed comparative advantage index and also static and dynamic intra-industry trade (IIT) indices were used in the period 2000â€“2012.

Results: The results indicated the growing competitiveness in most of the selected countries. Furthermore, the findings suggested that countries with higher levels of international trading of pharmaceutical goods have a higher potential of competitiveness based on IIT and comparative advantage indices.

Conclusions: For increase in international competitiveness in pharmaceutical industry, selected developed countries pay attention to both comparative and competitive advantages.

Downloads

Download data is not yet available.

References

Imani A, Janati A, Moghimi M, Golestani M, Doshmangir L. Identification of indicators for evaluating the financial and economic performance of the pharmacy: A systematic review. Pharm Sci 2015;21:111-24.

Salari A, Dezh pasand F. Comparative advantage in petroleum of Iran. Q Econ Trade 2007;9:84-111.

Mostafavi SH, Takshi N. To define the effect of absolute and comparative advantage of export on development of economy. Meysagh Iran Mag 2008;32:66-72.

Rasekhi S. IIT between Iran and Main Trading Partners. 3rd ed. Tehran; Commercial Research and Study Center: 2013.

International Federation of Pharmaceutical Manufacturers and Associations [IFPMA]. The Pharmaceutical Industry and Global Health. Geneva: International Federation of Pharmaceutical Manufacturers and Associations; 2012.

Esfandiari KH, Yousefi P. Threats and Opportunities for Drugs Economy. Annual Iranian Conferences of Pharmaceutical and Treatment Economics. Tehran; 2011. p 1-19. Available from: http://www.ipte90.cnf.ir/files_site/paperlist/r_12_120416074804.pdf.

Vollrath TL. Weltwirtschaftliches Arch 1991;130:265-79.

Utkulu U, Seymen D. Revealed Comparative Advantage and Competitiveness: Evidence for Turkey visÃ -vis the EU/15. To be presented at the European trade study Group 6th Annual Conference, Nottingham; 2004, 2004. p. 1-26.

Brasili A, Epifani P, Helg R. On the dynamics of trade pattern. Economist 2000;148:233-57.

Rasekhi S. Measuring IIT: A case study of factory based industries of Iran. J Econ Res 2007;81:61-84.

BrÃ¼lhart M. Marginal Intra-Industry Trade: Towards a measure of non-disroptive trade expantion. In: Lioyd PJ, Lee HH, editors. Frontiers of Research on Intra Industry Trade. London: Palgrave; 2002. p. 1-26.

Tahmasebi N, Zadeh AK, Imani A, Golestani M. Evaluation of factors affecting sales of prescription medicines by econometric methods in Iran. Pharm Sci 2013;19:101-7.

Khanduzi E. To study the Power of Iran`s Economy in Globalization. MA Thesis. Tehran: Emam Sadegh University; 2005.

Appelyard DR, Alfred JF. International Economy: Trade Theory and Policy. USA: Library of Congress; 1995.

Davis DR. Intra-industry trade a hecksher-ohlin-ricardo approach. J Int Econ 1995;39:207-26.

Jafari Samimi A, Naghavi S. To study comparative advantage of value added of economic sectors in Khorasan based on third development plan. Danesh Tose`e Q 2008;23:1-24.

Chaharbaghi K, Lynch R. Sustainable competitive advantage: Towards a dynamic resource-based strategy. Manage Decis 1999;37:45-50.

Neary PJ. Competitive versus Comparative Advantage Lectures in the Department of Economics. Working Paper; 2002. p. 1-24.

Veermani CH. Liberalisation, Industry-Specific Factors and Intre-Industry Trade in Indi. Vol. 97. Working Paper; 2003. p. 32-47.

Pradhan JP. Global competitiveness of indian pharmaceutical industry: Trends and strategies. Munich Per Repec Arch 2006;12340:35-69.

Olmeda G, Varela J. Determinants of international competitiveness in the pharmaceutical industry. Esic Market Econ Bus J 2012;2:372-82.

Ito T, Okubo T. New Aspects of Intra-Industry Trade in Euro Countries. Inst Dev Econ 2012;361:20-40.

Kalbasi H, Raeesi Ardali GH, Raeesi M. Estimates of intra industry trade, Iran. J Econ Res 2004;20:55-79.

Golestani M, Rasekh HR, Imani A. The relationship between pharmaceutical expenditures, health care expenditures and gross domestic product in Iran: 1999-2008. Pharm Sci 2012;18:9-18.

Mahmood Zadeh M, Karimi M, Hasan Pour Y. Analysis of Iran`s power in medicine exports. Sci Res Mag Econ Policy 2012;7:57-78.

Nasabian SH, Gholam Hosseini T, Jebel Ameli F. To compare the comparative advantage of exporting herbal medicines with other exporting countries. Q Econ Model 2013;4:1-18.

Ebrahim E, Shabaninejad H, Madani H, Amineh ZA. A framework for evaluation of pharmaceutical industry development in developing countries: Evidence from Iran. Asian J Pharm Clin Res 2016;9:50-4.

Alamelu R, Amudha R, Shakila Motha LC, Nalini R. Pharma export: Comforts and confronts in India. Asian J Pharm Clin Res 2016;9:24-6.